Ultra Clean (UCTT): Beat by $57M, Burned $100M of Cash. Is UCTT Stock a Buy?

Ultra Clean Holdings, Inc. (UCTT) Q2 2026 — Reported August 3, 2026 after the US close for Q2 2026 (the quarter ended June 26, 2026). Revenue $644.9M (+24.3% YoY, +20.8% QoQ) vs a $587.6M consensus and the company's own $565-605M guidance - a beat above the TOP END. Products $572.7M (+25.9%), Services $72.2M (+13.0%). GAAP gross margin 16.1%, operating margin 4.6%, net income attributable to UCT $8.7M or $0.19/sh. Non-GAAP gross margin 16.7%, operating margin 7.0%, net income $32.3M or $0.70/sh vs a $0.531 consensus. Q3 2026 guidance: revenue $700-750M (+12% QoQ at the midpoint, +42% YoY), GAAP EPS $0.67-0.87, non-GAAP EPS $0.83-1.03. Shares closed the regular session at $89.17 (+7.0%) BEFORE the release; the reaction session had not opened when this episode was recorded, and UCTT traded around $96.84 in the pre-market, about +8.6%. The stock is up more than 300% from its $21.63 low of August 6, 2025 and 37% below its $142.59 high of June 30, 2026. The line nobody printed: revenue grew 24% and free cash flow was MINUS $100.2M. First-half operating cash flow was -$74.4M against +$57.4M a year ago - a $131.8M swing - and capex took another $25.8M. The bridge is one line: inventories consumed $238.9M of cash, with the balance going from $390.9M in December to $629.9M in June, roughly 106 days on hand against ~83 at year end. Accounts payable gave back $104.4M, so part of the build is being funded by stretching suppliers. Two more things nobody flagged. FIRST, the refinancing is doing about 40% of the earnings growth: interest expense fell to $1.1M from $10.1M after March's $600M 0.00% convertible notes replaced $481.5M of bank debt - roughly $0.16/sh after tax out of a $0.37 YoY improvement in non-GAAP EPS - and those notes convert at $84.75, below the $89.17 close, carrying 7.1M shares or 15.4% dilution. SECOND, the Q3 guide implies a GAAP-to-non-GAAP gap of just $0.16 against $0.51 this quarter; intangible amortisation alone is $0.15/qtr, so the US tax valuation allowance drag has to essentially vanish - a one-time, non-cash benefit, not earnings power. THE CALL: AVOID (3/5, A GREAT QUARTER AT A PRICE WE CANNOT UNDERWRITE) — base-case value ~$62.0 vs ~$89.17 today. KEY METRICS: - CALL: AVOID 3/5 - fair value ~$62 vs the $89.17 close (about -30%), and below the LOWEST price target on Wall Street ($70). This is not a call on the business, which is executing; it is a call on the price of entry. DCF on free cash flow AFTER charging stock-based compensation as a real cost: revenue from ~$2.67B (2026E) to $3.81B by 2031, non-GAAP operating margin 7.0% -> 9.0%, SBC ~$36M growing 5%/yr, capex 2.6% of revenue vs D&A 1.9%, and working capital taking 20 cents of every incremental revenue dollar. At 10.5% and 2.5% terminal growth: PV of 2027-2031 FCF $476M + PV of terminal value $1,444M = EV $1,920M, less $343.5M net debt and $77.3M of noncontrolling interests, / 46.1M diluted shares = $32.52. Bear $12.20, bull $58.51; probability-weighted 25/50/25 = ~$34. We carry ~$62 because semi-cap is priced on mid-cycle earnings multiples, not on DCF: $3.25 of mid-cycle non-GAAP EPS at 18x is $58.50, and $5.00 of peak 2027 EPS at 16x is $80. - REVERSE DCF - THE WHOLE ARGUMENT: at $89.17 the market capitalisation is $4.11B on 46.1M diluted shares and enterprise value is $4.53B - 1.69x revenue and 24.5x our FY2026 non-GAAP operating income estimate of $185M. Growth does NOT close the gap: we tested a 20% five-year revenue CAGR and the model still prints $28, because every incremental dollar of revenue drags ~20 cents of working capital with it. What $89.17 requires is a terminal OPERATING margin near 17% - against a GROSS margin of 16.7%. The discounted cash flow cannot get there at all, at any discount rate: even at an implausibly generous 7.5%, the base case is under $60. - THE CASH: first-half operating cash flow -$74.4M (vs +$57.4M a year ago) less $25.8M capex = -$100.2M of free cash flow, against +$28.2M in the same half of 2025. Inventories consumed $238.9M; the balance rose from $390.9M (12/26/25) to $629.9M (6/26/26), about 106 days of cost of revenue vs ~83 at year end. Accounts payable +$104.4M. Cash fell from $311.8M to $255.9M despite raising $600M of converts. For every $1 of gross profit earned in the half, UCT put roughly $2 of parts on a shelf. - THE BALANCE SHEET: $600M of 0.00% convertible senior notes due March 15, 2031 issued March 3, 2026 (net proceeds ~$583.3M), used to repay $481.5M of bank debt. Cash $255.9M, long-term debt $599.4M, NET DEBT $343.5M - about 1.5x annualised Q2 non-GAAP EBITDA. This is NOT a net-cash balance sheet. Conversion price $84.75/sh (11.80 shares per $1,000, a 42.5% premium to the $59.47 close of 2/26/26) - the $89.17 close is ABOVE it, so the notes are in the money; full conversion is 7.1M shares, 15.4% of the diluted count. $25.1M was paid for capped calls. The February 2026 Ninth Amendment temporarily raised the permitted gross leverage covenant to 6.00x for the March and June 2026 periods. Interest expense $1.1M vs $10.1M a year ago. - CUSTOMER CONCENTRATION AND GEOGRAPHY (Q1 2026 10-Q, the most recent disclosure): Lam Research 36.7% of revenue and Applied Materials 21.8% = 58.5% from two customers. Lam, Applied and ASM International were each over 10% of gross receivables, ~39% in aggregate. Revenue shipped to China was only $24.8M, 4.6% of the total, and DOWN from $33.3M a year earlier - the direct China exposure is small, but the indirect exposure through Lam's and Applied's own China business is not. Singapore $203.2M (38%), United States $129.4M, Austria $57.2M, South Korea $28.2M, Malaysia $24.8M, Taiwan $16.6M. - SEGMENTS AND MARGIN STRUCTURE: Products $572.7M (89% of revenue) at a 14.6% GAAP gross margin and 4.3% segment operating margin; Services $72.2M (11%) at a 27.4% gross margin and 6.6% operating margin - the small segment is nearly twice as profitable, and it is growing at 13% while the low-margin half grows at 26%. Non-GAAP operating income went from $27.1M (Q1) to $45.1M (Q2) on $111.2M of incremental revenue - a 16.2% INCREMENTAL operating margin, our math. GAAP effective tax rate 60.3% because US losses carry a full federal and state valuation allowance (non-GAAP rate 20%); that item alone is $0.26 of the $0.51 gap between $0.19 GAAP and $0.70 non-GAAP EPS. A year ago this quarter UCT wrote off $151.1M of goodwill; $114.2M remains. - WHY WE ARE BELOW THE STREET: consensus is Buy - 8 buy / 4 hold / 0 sell across 12 analysts with live targets - at an average target of $103.75, median $107.50, high $130, low $70. Recent moves: TD Cowen to $130 (July, from $100), UBS initiating at $130 (May), Oppenheimer $115 (June, from $100), Needham $92 (from $70). The Street sees +16% upside; we see -30% downside. We DIFFER and are far more CAUTIOUS - but note WHERE: we are not arguing with the revenue. The WFE upcycle and the AI datacenter capex driving it are real, and the Q3 guide is real. We are arguing with the margin, the customer concentration and the cash conversion. SHARE COUNT read off the press release EPS table: 45.1M basic / 46.1M diluted. What to watch: Bullish: operating cash flow turning sharply positive in Q3/Q4 as the $239M inventory build converts, which would prove it was pre-positioning rather than a pull-in; or non-GAAP gross margin clearing 18% and holding. Either moves our number toward $80. Bearish: Q3 revenue landing at the low end of the $700-750M guide with inventory still rising, or the Products gross margin slipping back under 14% as Lam and Applied press on price. Either takes us closer to $45. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.